je.st
news
The Angeles Clinic and Research Institute Releases Interim Data from...
2013-06-05 09:48:23| Logistics - Topix.net
The Angeles Clinic and Research Institute has released preliminary results from an ongoing Phase IB expansion study evaluating the safety and efficacy of lambrolizumab , an investigational antibody therapy currently being developed by Merck that targets programmed cell death-1 protein in patients with advanced melanoma.
Tags: from
data
research
angeles
Category:Transportation and Logistics